Blood pressure medicine recall: Thousands of bottles pulled nationwide

Macleods Pharma USA has issued a nationwide recall for thousands of bottles of blood pressure medication due to failure to meet dissolution specifications. The FDA classified this as a Class II recall, noting that while serious health risks are remote, the pills may not work as intended.
Why it matters
Pharmaceutical recalls are critical for public health, ensuring that patients are not relying on ineffective or potentially harmful medication.
Americans who take medication for high blood pressure may want to check their medicine cabinets after thousands of bottles of a prescription drug were recalled nationwide. New Jersey-based Macleods Pharma USA is recalling certain lots of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablets after the medication failed to meet federal quality standards, according to the U.S. Food and Drug Administration (FDA). The recall covers 3,528 30-count bottles from lot 12251163A and 216 90-count bottles from lot 12251163B. Both lots expire May 31, 2027. NEARLY 6 MILLION COFFEE MAKERS SOLD AT MAJOR RETAILERS RECALLED OVER BURN RISK Consumers can check their prescription bottles for the lot number and National Drug Code, or NDC. The recalled 30-count bottles have NDC 33342-246-07, while the 90-count bottles have NDC 33342-246-10. The FDA listed the reason for the recall as "failed dissolution specifications," meaning the pills did not dissolve as required during testing.
Also covering this story
One other newsroom covered this event. We read that version too.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in